isoxazoles has been researched along with Adenocarcinoma, Basal Cell in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (25.00) | 18.7374 |
1990's | 1 (6.25) | 18.2507 |
2000's | 1 (6.25) | 29.6817 |
2010's | 8 (50.00) | 24.3611 |
2020's | 2 (12.50) | 2.80 |
Authors | Studies |
---|---|
Czerski, A; Czyżnikowska, Ż; Jęśkowiak, I; Mączyński, M; Regiec, A; Sochacka-Ćwikła, A; Wiatrak, B | 1 |
Cheng, B; Li, D; Liu, Y; Song, Y; Wang, Q; Yang, S; Zhang, Y; Zhu, C | 1 |
Azzoli, CG; Costa, DB; Gainor, JF; Heist, RS; Huberman, M; Lennes, IT; Muzikansky, A; Oxnard, GR; Piotrowska, Z; Sequist, LV; Shaw, AT | 1 |
Basu, G; Bhattacharyya, B; Chakrabarti, P; Chakraborti, G; Chakraborti, S; Das, A; Dhar, G; Dwivedi, V; Poddar, A; Surolia, A | 1 |
Fernandes, J; Jampol, LM; Johnson, ML; Mets, M; Munk, MR; Patel, JD | 1 |
Biederman, RW; Boyd, NH; DiCarlo, C; Finley, G; Jobe, BA; Kelly, LA; Kolano, EL; Komatsu, Y; Kosovec, JE; Landreneau, RJ; Matsui, D; Omstead, A; Rotoloni, CL; Silverman, JF; Vytlacil, C; Zaidi, AH | 1 |
Hedley, D; Krzyzanowska, MK; Moore, MJ; Renouf, DJ; Schmuck, M; Wang, L | 1 |
Chihong, Z; Danying, W; Dong, Y; Huaying, S; Jianguo, F; Xiaoqian, Q | 1 |
Bucala, R; Crichlow, GV; Leng, L; Lolis, E; Meier, J; Mitchell, RA; Rendon, BE; Riggs, R; Smith, N; Trent, JO; Winner, M; Zierow, S | 1 |
Cebrián, C; Conde, B; Esquivias, P; Esteva, F; Jiménez, P; Lanas, A; Ortego, J; Piazuelo, E; Santander, S | 1 |
Gibbs, TC; Knoepp, SM; Meier, KE; Park, JJ; Rubio, MV; Snider, AJ; Um, T; Xie, Y; Zhang, Z | 1 |
Arakawa, M; Ardalan, B; Cooney, DA; Jayaram, H; Villacorte, D | 1 |
Cripps, C; Eisenhauer, E; Fields, AL; Maroun, JA; Pater, JL; Stewart, DJ | 1 |
Bakker, CT; Jansen, PL; Oude Elferink, RP | 1 |
Davis, TE; Earhart, RH; Faraggi, D; Khandekar, JD; Schinella, RA | 1 |
Booth, BW; Budman, D; Ellison, RR; Khojasteh, A; Korzun, AH; Weiss, RB; Wood, W | 1 |
4 trial(s) available for isoxazoles and Adenocarcinoma, Basal Cell
Article | Year |
---|---|
Activity of the Hsp90 inhibitor luminespib among non-small-cell lung cancers harboring EGFR exon 20 insertions.
Topics: Adenocarcinoma; Adult; Aged; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cohort Studies; ErbB Receptors; Exons; Female; Follow-Up Studies; HSP90 Heat-Shock Proteins; Humans; Isoxazoles; Lung Neoplasms; Male; Middle Aged; Mutagenesis, Insertional; Prognosis; Resorcinols; Survival Rate | 2018 |
A phase II study of the HSP90 inhibitor AUY922 in chemotherapy refractory advanced pancreatic cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carcinoma, Pancreatic Ductal; Disease-Free Survival; Female; HSP90 Heat-Shock Proteins; Humans; Isoxazoles; Male; Middle Aged; Neoplasm Metastasis; Resorcinols; Survival Rate; Treatment Outcome | 2016 |
Phase II trial of continuous drug infusions in advanced ovarian carcinoma: acivicin versus vinblastine.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Drug Evaluation; Female; Humans; Infusions, Intravenous; Isoxazoles; Middle Aged; Ovarian Neoplasms; Oxazoles | 1989 |
Phase II trial of acivicin in advanced breast carcinoma: a Cancer and Leukemia Group B Study.
Topics: Adenocarcinoma; Aged; Antibiotics, Antineoplastic; Brain Diseases; Breast Neoplasms; Clinical Trials as Topic; Drug Evaluation; Female; Hematologic Diseases; Humans; Isoxazoles; Middle Aged; Neoplasm Metastasis; Oxazoles | 1986 |
12 other study(ies) available for isoxazoles and Adenocarcinoma, Basal Cell
Article | Year |
---|---|
New Oxazolo[5,4-
Topics: Adenocarcinoma; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Cell Proliferation; Cisplatin; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Fluorouracil; Humans; Isoxazoles; Molecular Docking Simulation; Molecular Structure; Purines; Pyrimidines; Structure-Activity Relationship; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2022 |
MIF inhibitor, ISO-1, attenuates human pancreatic cancer cell proliferation, migration and invasion in vitro, and suppresses xenograft tumour growth in vivo.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Biological Assay; Cell Line, Tumor; Cell Movement; Cell Proliferation; Diffusion Chambers, Culture; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Humans; Intramolecular Oxidoreductases; Isoxazoles; Macrophage Migration-Inhibitory Factors; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Pancreatic Neoplasms; RNA, Messenger; Signal Transduction; Transcription Factor RelA; Tumor Burden; Tumor Necrosis Factor-alpha; Xenograft Model Antitumor Assays | 2020 |
Stable and potent analogues derived from the modification of the dicarbonyl moiety of curcumin.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Cell Proliferation; Curcumin; Flow Cytometry; Free Radical Scavengers; Humans; Isoxazoles; Ketones; Lung Neoplasms; Models, Chemical; Molecular Conformation; Molecular Structure; Pyrazoles; Structure-Activity Relationship; Tubulin; Tumor Cells, Cultured | 2013 |
Reversible nyctalopia and retinopathy in a patient with metastatic cancer treated with anti-heat shock protein 90 therapy.
Topics: Adenocarcinoma; Aged; Autoantibodies; Autoantigens; Electroretinography; Erlotinib Hydrochloride; HSP90 Heat-Shock Proteins; Humans; Infusions, Intravenous; Isoxazoles; Lung Neoplasms; Male; Night Blindness; Paraneoplastic Syndromes, Ocular; Phosphopyruvate Hydratase; Quinazolines; Resorcinols; Retina; Tomography, Optical Coherence; Visual Acuity | 2014 |
Preclinical Study of AUY922, a Novel Hsp90 Inhibitor, in the Treatment of Esophageal Adenocarcinoma.
Topics: Adenocarcinoma; Animals; Apoptosis; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Esophageal Neoplasms; HSP90 Heat-Shock Proteins; Isoxazoles; Male; Rats; Rats, Sprague-Dawley; Resorcinols | 2016 |
Transglutaminase 2 Inhibitor KCC009 Induces p53-Independent Radiosensitization in Lung Adenocarcinoma Cells.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Clone Cells; Enzyme Inhibitors; GTP-Binding Proteins; Humans; Isoxazoles; Lung Neoplasms; Protein Glutamine gamma Glutamyltransferase 2; Radiation-Sensitizing Agents; Radiation, Ionizing; Transglutaminases; Tumor Suppressor Protein p53 | 2016 |
A novel, macrophage migration inhibitory factor suicide substrate inhibits motility and growth of lung cancer cells.
Topics: Adenocarcinoma; Cell Growth Processes; Cell Line, Tumor; Cell Movement; Humans; Intramolecular Oxidoreductases; Isoxazoles; Lung Neoplasms; Macrophage Migration-Inhibitory Factors; Models, Molecular; Pyrimidines | 2008 |
Cyclooxygenase inhibitors decrease the growth and induce regression of human esophageal adenocarcinoma xenografts in nude mice.
Topics: Adenocarcinoma; Aged; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Esophageal Neoplasms; Female; Gene Expression; Humans; Indomethacin; Isoxazoles; Male; Mice; Mice, Nude; Random Allocation; Receptors, Prostaglandin E; Tumor Burden; Xenograft Model Antitumor Assays | 2012 |
Effects of lysophosphatidic acid on calpain-mediated proteolysis of focal adhesion kinase in human prostate cancer cells.
Topics: Adenocarcinoma; Animals; Calpain; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Survival; Drug Screening Assays, Antitumor; Fibroblasts; Focal Adhesion Protein-Tyrosine Kinases; Humans; Ionomycin; Isoxazoles; Lysophospholipids; Male; Paxillin; Phosphorylation; Propionates; Prostatic Neoplasms; Proteolysis; Rats; Thapsigargin | 2012 |
Effect of L-glutamine antagonists on 5-phosphoribosyl 1-pyrophosphate levels in P388 leukemia and in murine colon adenocarcinomas in vivo.
Topics: Adenocarcinoma; Animals; Azaserine; Colonic Neoplasms; Diazooxonorleucine; Glutamine; Intestine, Small; Isoxazoles; Leukemia P388; Leukemia, Experimental; Mice; Neoplasms, Experimental; Pentosephosphates; Phosphoribosyl Pyrophosphate | 1982 |
Phase II study of acivicin in colorectal carcinoma: a National Cancer Institute of Canada study.
Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Central Nervous System Diseases; Colonic Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Hematologic Diseases; Humans; Infusions, Parenteral; Isoxazoles; Male; Middle Aged; Oxazoles; Rectal Neoplasms | 1984 |
Glutathione-conjugate transport by human colon adenocarcinoma cells (Caco-2 cells).
Topics: Adenocarcinoma; Adenosine Triphosphate; Biological Transport, Active; Chromatography, High Pressure Liquid; Colonic Neoplasms; Dinitrochlorobenzene; Dinitrophenols; gamma-Glutamyltransferase; Glutathione; Glutathione Transferase; Humans; Isoxazoles; Tumor Cells, Cultured | 1993 |